$BIOA stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $2,872,322 of trading volume.
Here is what we see in our data on $BIOA (you can track the company live on Quiver's $BIOA stock page):
$BIOA Insider Trading Activity
$BIOA insiders have traded $BIOA stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $BIOA stock by insiders over the last 6 months:
- KRISTEN FORTNEY (Chief Executive Officer) sold 233,107 shares for an estimated $4,223,036
- PAUL D RUBIN (Chief Medical Officer) has made 0 purchases and 5 sales selling 110,583 shares for an estimated $1,309,852.
- DOV A MD GOLDSTEIN (Chief Financial Officer) has made 0 purchases and 4 sales selling 27,000 shares for an estimated $531,827.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BIOA Hedge Fund Activity
We have seen 64 institutional investors add shares of $BIOA stock to their portfolio, and 32 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAR1 CAPITAL MANAGEMENT, LLC removed 1,744,513 shares (-92.8%) from their portfolio in Q4 2025, for an estimated $23,079,906
- TANG CAPITAL MANAGEMENT LLC removed 1,600,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $21,168,000
- OCTAGON CAPITAL ADVISORS LP added 1,598,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,141,540
- JANUS HENDERSON GROUP PLC added 409,207 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,413,808
- SIREN, L.L.C. removed 382,406 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,059,231
- DIADEMA PARTNERS LP added 271,164 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,587,499
- ACADIAN ASSET MANAGEMENT LLC added 267,281 shares (+2503.6%) to their portfolio in Q4 2025, for an estimated $3,536,127
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BIOA Analyst Ratings
Wall Street analysts have issued reports on $BIOA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 02/18/2026
- Citigroup issued a "Buy" rating on 10/29/2025
To track analyst ratings and price targets for $BIOA, check out Quiver Quantitative's $BIOA forecast page.
$BIOA Price Targets
Multiple analysts have issued price targets for $BIOA recently. We have seen 6 analysts offer price targets for $BIOA in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Joseph Stringer from Needham set a target price of $50.0 on 03/27/2026
- Samantha Semenkow from Citigroup set a target price of $52.0 on 03/10/2026
- Jay Olson from Oppenheimer set a target price of $60.0 on 02/25/2026
- Roger Song from Jefferies set a target price of $62.0 on 02/18/2026
- Yasmeen Rahimi from Piper Sandler set a target price of $73.0 on 01/27/2026
- Jeffrey Hung from Morgan Stanley set a target price of $12.0 on 12/08/2025
You can track data on $BIOA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
